Immunoreactivity assessment of hepatitis C virus NS3 protease and NS5A proteins expressed in TOPO cloning system

1999, Hepatitis C global prevalence (update), Wkly Epidemiol Rec, 74, 425 Choo, 1989, Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science, 244, 359, 10.1126/science.2523562 Kuo, 1989, An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis, Science, 244, 362, 10.1126/science.2496467 Davis, 2003, Projecting future complications of chronic hepatitis C in the United States, Liver Transpl, 9, 331, 10.1053/jlts.2003.50073 Friebe, 2002, Genetic analysis of sequences in the 3′-nontranslated region of hepatitis C virus that are important for RNA replication, J Virol, 76, 5326, 10.1128/JVI.76.11.5326-5338.2002 Ohba, 1996, Evolutionary relationship of hepatitis C, pesti-, flavi-plantviruses, and newly discovered GB hepatitis agents, FEBS Lett, 378, 232, 10.1016/0014-5793(95)01441-1 Simons, 1995, Isolation of novel virus-like sequences associated with human hepatitis, Nat Med, 1, 564, 10.1038/nm0695-564 Davis, 1999, Hepatitis C virus genotypes and quasispecies, Am J Med, 107, 21, 10.1016/S0002-9343(99)00376-9 Grakoui, 1993, Characterization of hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites, J Virol, 67, 2832, 10.1128/JVI.67.5.2832-2843.1993 Hijikata, 1993, Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus, Proc Natl Acad Sci U S A, 90, 10773, 10.1073/pnas.90.22.10773 Diviney, 2008, A hepatitis C virus cis-acting replication element forms a long-range RNA–RNA interaction with upstream RNA sequences in NS5B, J Virol, 82, 9008, 10.1128/JVI.02326-07 Takamizawa, 1991, Structure and organization of the hepatitis C virus genome isolated from human carriers, J Virol, 65, 1105, 10.1128/JVI.65.3.1105-1113.1991 Hijikata, 1993, Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus, J Virol, 67, 4665, 10.1128/JVI.67.8.4665-4675.1993 Yao, 1999, Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease—helicase, Structure, 7, 1353, 10.1016/S0969-2126(00)80025-8 Bartenschlager, 1995, Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase, J Virol, 69, 198, 10.1128/JVI.69.1.198-205.1995 Kolykhalov, 2000, Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo, J Virol, 74, 2046, 10.1128/JVI.74.4.2046-2051.2000 Lesk, 1996, Conservation and variability in the structures of serine proteinases of the chymotrypsin family, J Mol Biol, 258, 501, 10.1006/jmbi.1996.0264 Neddermann, 1997, The non-structural proteins of the hepatitis C virus: structure and function, Biol Chem, 378, 469 Manabe, 1994, Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3, Virology, 198, 636, 10.1006/viro.1994.1075 Barbato, 2000, Inhibitor binding induces active site stabilisation of the HCV NS3 protein serine protease domain, EMBO J, 19, 1195, 10.1093/emboj/19.6.1195 Cicero, 1999, Structural characterization of the interactions of optimised product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modeling studies, J Mol Biol, 289, 385, 10.1006/jmbi.1999.2746 Love, 1996, The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site, Cell, 87, 331, 10.1016/S0092-8674(00)81350-1 McPhee, 2003, Hepatitis C virus NS3 serine protease as a drug discovery target, Drugs Future, 28, 465, 10.1358/dof.2003.028.05.734774 Steinkuhler, 1998, Product inhibition of the hepatitis C virus NS3 protease, Biochemistry, 37, 8899, 10.1021/bi980313v Abian, 2009, Thermodynamics of zinc binding to hepatitis C virus NS3 protease: a folding by binding event, Proteins, 77, 624, 10.1002/prot.22475 Abian, 2010, Conformational stability of hepatitis C virus NS3 protease, Biophys J, 99, 3811, 10.1016/j.bpj.2010.10.037 El Hefnawi, 2009, Natural genetic engineering of hepatitis C virus NS5A for immune system counterattack, Ann N Y Acad Sci, 1178, 173, 10.1111/j.1749-6632.2009.05003.x Tellinghuisen, 2005, Structure of the zinc-binding domain of an essential replicase component of hepatitis C virus reveals a novel fold, Nature, 435, 374, 10.1038/nature03580 Macdonald, 2004, Hepatitis C virus NS5A: tales of a promiscuous protein, J Gen Virol, 85, 2485, 10.1099/vir.0.80204-0 Schmitz, 2008, NS5A—from obscurity to new target for HCV therapy, Recent Pat Anti-infect Drug Discov, 3, 77, 10.2174/157489108784746597 Moradpour, 2007, Replication of hepatitis C virus, Nat Rev Microbiol, 5, 453, 10.1038/nrmicro1645 Hughes, 2009, A conserved proline between domains II and III of hepatitis C virus NS5A influences both RNA replication and virus assembly, J Virol, 83, 10788, 10.1128/JVI.02406-08 Uyttendaele, 1994, Evaluation of third-generation screening and confirmatory assays for HCV antibodies, Vox Sang, 66, 122, 10.1111/j.1423-0410.1994.tb00293.x Neville, 1997, Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus, J Clin Microbiol, 35, 3062, 10.1128/JCM.35.12.3062-3070.1997 Beld, 1999, Quantitative antibody responses to structural (core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood, Hepatology, 29, 1288, 10.1002/hep.510290442 Dou, 2002, Antigenic heterogeneity of the hepatitis C virus NS5A protein, J Clin Microbiol, 40, 61, 10.1128/JCM.40.1.61-67.2002 Sillanpää, 2009, Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection, Virol J, 6, 84, 10.1186/1743-422X-6-84 El-Shamy, 2007, Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera, Microbiol Immunol, 51, 471, 10.1111/j.1348-0421.2007.tb03922.x Huang, 2004, Purification and characterization of hepatitis C virus non-structural protein 5A expressed in Escherichia coli, Protein Expr Purif, 37, 144, 10.1016/j.pep.2004.05.005 Ivanov, 2006, Development of the system ensuring a high-level expression of hepatitis C virus nonstructural NS5B and NS5A proteins, Protein Expr Purif, 48, 14, 10.1016/j.pep.2006.02.011 Poliakov, 2002, Expression and purification of recombinant full-length NS3 protease-helicase from a new variant of hepatitis C virus, Protein Expr Purif, 25, 363, 10.1016/S1046-5928(02)00042-6 Hou, 2003, In vitro assay for HCV serine proteinase expressed in insect cells, World J Gastroenterol, 9, 1629, 10.3748/wjg.v9.i7.1629 Colin, 2001, Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature, J Viral Hepat, 8, 87, 10.1046/j.1365-2893.2001.00280.x Pawlotsky, 1996, Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay, J Clin Microbiol, 34, 80, 10.1128/JCM.34.1.80-83.1996 Lin, 2005, Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus specific antibodies, J Clin Microbiol, 43, 3917, 10.1128/JCM.43.8.3917-3924.2005 Kalamvoki, 2002, Expression of immunoreactive forms of the hepatitis C NS5A protein in E. coli and their use for diagnostic assays, Arch Virol, 147, 1733, 10.1007/s00705-002-0836-0